Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

p105 Inhibitors

The class of compounds known as p105 inhibitors comprises a diverse group of molecules that primarily target the nuclear factor kappa B (NF-κB) pathway, specifically focusing on the precursor protein p105, which is an integral component of the NF-κB signaling cascade. The NF-κB pathway plays a pivotal role in regulating various cellular processes, including immune response, inflammation, and cell survival. Central to this pathway is the p105 protein, a precursor of the p50 subunit of NF-κB. The p105 inhibitor class includes a range of chemical entities with distinct structures and modes of action, all aimed at modulating the NF-κB pathway by influencing p105 processing and the subsequent activation of NF-κB.

These inhibitors exert their effects by interfering with critical steps in the NF-κB activation process. One common mechanism involves the blockade of IκB kinase (IKK) activity, preventing the phosphorylation and degradation of IκBα, which is a key regulatory protein that sequesters NF-κB in the cytoplasm. By inhibiting IKK activity, p105 inhibitors indirectly hamper the proteasomal degradation of IκBα, thereby halting the release of active NF-κB subunits. Moreover, certain p105 inhibitors target the proteolytic processing of p105 itself. In the canonical NF-κB pathway, p105 serves as a precursor to the p50 subunit. These inhibitors impede the processing of p105 into p50 by inhibiting enzymes responsible for this cleavage, effectively curtailing the availability of active NF-κB subunits. As a result, the cellular response to various stimuli that trigger NF-κB activation is diminished. The complexity and diversity of the p105 inhibitor class reflect the intricate regulatory network of the NF-κB pathway. These compounds offer valuable tools for researchers studying cellular signaling and inflammation, aiding in the deciphering of NF-κB-mediated processes. Through their influence on p105 processing and NF-κB activation, p105 inhibitors contribute to our understanding of fundamental biological pathways and hold the ability to uncovering new insights into cellular behavior beyond their explored applications.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$62.00
$85.00
$356.00
155
(1)

Inhibits NF-κB activation by blocking IκBα phosphorylation.

NFκB Activation Inhibitor II, JSH-23

749886-87-1sc-222061
sc-222061C
sc-222061A
sc-222061B
5 mg
10 mg
50 mg
100 mg
$214.00
$257.00
$1775.00
$2003.00
34
(1)

Selectively inhibits p105 processing, preventing NF-κB activation.

IKK-2 Inhibitor IV

507475-17-4sc-203083
500 µg
$133.00
12
(1)

Blocks p105 processing and nuclear translocation of NF-κB.

IMD 0354

978-62-1sc-203084
5 mg
$199.00
3
(1)

Inhibits the translocation of p50 subunit, suppressing NF-κB.

ML 120B Dihydrochloride

783348-36-7 (free base)sc-487759
5 mg
$380.00
(0)

Targets TAK1 kinase, disrupting the activation of p105 processing.

SC514

354812-17-2sc-205504
sc-205504A
5 mg
10 mg
$67.00
$91.00
13
(2)

Suppresses IκBα kinase activity, preventing p105 degradation.

BMS-345541

445430-58-0sc-221741
1 mg
$312.00
1
(1)

Selectively inhibits IKKβ, leading to p105 stabilization.

Celastrol, Celastrus scandens

34157-83-0sc-202534
10 mg
$158.00
6
(1)

Reduces p105 phosphorylation and impedes NF-κB activation.

Parthenolide

20554-84-1sc-3523
sc-3523A
50 mg
250 mg
$81.00
$306.00
32
(2)

Blocks IκBα phosphorylation, preventing p105 degradation.

Withaferin A

5119-48-2sc-200381
sc-200381A
sc-200381B
sc-200381C
1 mg
10 mg
100 mg
1 g
$130.00
$583.00
$4172.00
$20506.00
20
(1)

Modulates NF-κB pathway, affecting p105 processing and stability.